CT procedure volumes increased 9.1% from 2022 to 2023.
ARLINGTON, Va., Nov. 13, 2023 /PRNewswire-PRWeb/ — CT procedure volumes increased 9.1% from 2022 to 2023, according to IMV’s recently published 2023 CT Market Outlook Report. While both hospital and non-hospital CT procedure volumes increased, hospital volumes increased year-over-year by almost 10% while, non-hospital volumes increased at just over 6%.‥
Looking ahead into 2024, 72% of CT sites surveyed anticipate that their 2024 CT procedures will increase compared to 2023, while 23% expect them to stay the same and just 1% of sites anticipate a decrease. One likely cause of the increase, with 60% of survey respondents rating 4 or 5 out of 5, is due to some procedures shifting from other imaging modalities to CT, according to the report.
When it comes to staff that will handle these potentially increased volumes, on average sites surveyed reported seven technologists per site (with a range of three technologists in independent imaging centers to 17 in hospitals with more than 400 beds).
Overall, the report found that in 2023, an average of two CT technologists are involved with performing and preparing patients for CT exams on each scanner in their facility. This varies across sites, with 34% of survey respondents reporting one technologist performing these duties, 48% of sites reporting two, and 17% of sites reporting three or more technologists to prepare patients for CT exams on each scanner.
Other key findings from the report include the following:
In 2023, the top priority for CT departments has been to “improve patient satisfaction with their CT experience,” with 92% of respondents rating this as a 4 or 5 out of 5.
As of this report, GE has 32% of the CT installed base market share, followed by Siemens (32%), Canon (18%), Philips (12%), and Fujifilm (5%).
CT procedure volumes have shown strong growth over the last few years, and as volumes continue to increase the more efficient sites with available technologist capacity are in the best position to realize the benefits from the increased volumes.‥‥
Want to share your knowledge of medical imaging? Click here to sign up for the IMV Survey panel today.‥
Davin Korstjens is a Senior Market Research Program Manager at IMV Medical Information Division, part of Science and Medicine Group.‥
IMV’s 2023 CT Market Outlook Report explores market trends related to service contracts for diagnostic imaging equipment in U.S. hospitals. The report was published in October 2023 and is based on responses from 313 radiology administrators and technicians who participated in IMV’s nationwide survey from July 2023 – August 2023. Vendors covered in this report include Bayer, Bracco, Canon, Fujifilm, GE Healthcare, Guerbet, Philips, Samsung, Siemens and United Imaging.‥
For information about purchasing IMV Market Outlook Reports, visit the corporate website at https://imvinfo.com/ or call 703-778-3080 ext. 1033 to speak with a representative. In addition to the report, all purchases will include a complimentary recording of an executive summary presentation of findings conducted by IMV’s Senior Program Manager.
Disclosure: IMV Medical Information Division is a sister company of AuntMinnie.com.
PDA’s Immediate-Past Chair passed on Oct. 24 following a bout with cancer.
BETHESDA, Md., Nov. 9, 2023 /PRNewswire-PRWeb/ — PDA today announced the establishment of the Jette Christensen Early Career Professional Grant in memory of the Immediate-Past Chair of the PDA Board of Directors, who passed away on October 24 after a long battle with cancer. As a PDA member, Board Member, and PDA Chair, Jette’s dedication to PDA’s mission of advancing pharmaceutical/biopharmaceutical manufacturing science and regulation so members can better serve patients benefited not only PDA members but the entire industry.
Created through the PDA Foundation for Pharmaceutical Education, Training, and Research, the Jette Christensen Early Career Professional Grant will provide funding for the development of the next generation of industry leaders which is reflective of one of Jette’s many passions. Early Career Professionals selected to receive this prestigious developmental grant will receive funding to enable their attendance at PDA’s technical conferences and training courses.
“The PDA organization is very saddened by the recent loss of our Immediate Past Chair and long-term PDA Member Jette Christensen,” said Glenn Wright, PDA President and CEO. “For over 25 years she was an active contributing member of PDA serving on various Conference Planning Committees, Advisory Boards, TR teams, Board of Directors including as Board Chair. Jette was very active even until just a few weeks before her passing, continuing as a member of the PDA Executive Committee in her role as Immediate Past Chair. Her commitment to PDA was unfaltering and we cannot thank her enough for all she has done. Knowing Jette personally for over 20 years, I will miss not only her love of life, engaging attitude but her insightful questions and wise counsel. She will be greatly missed by the entire PDA family.”
“Jette was a great lady with a beautiful and welcoming demeanor,” said Sue Schniepp, PDA Chair. “She taught me so much during the time I worked with her. I will miss her and will always remember her dignity and grace in everything she undertook.”
“I had the honor to work with Jette for her entire term on the PDA Board of Directors, up to and including her term as Chair of PDA,” said Richard Johnson, past PDA President and CEO. “Over the years I came to know her and her courage and determination. She was a leader who always included everyone’s input. She was considerate and kind and maintained her dedication despite her challenges. Jette also enjoyed interacting with a wide variety of people from around the world. Those of us who were fortunate to know her will always remember her with fondness.”
PDA formed the PDA Foundation for Pharmaceutical Education, Training and Research (PDAF) in 1997 for the following purposes:
To support the education, training and research activities of the Parenteral Drug Association, Inc.
To generally support education, training and research in the pharmaceutical sciences.
To increase awareness and educate the public on pharmaceutical sciences by disseminating information and presenting public discussion groups, forums, panels, lectures and other programs.
To do any and all other things which are consistent with its other goals and objectives.
Pull Quote
Created through the PDA Foundation for Pharmaceutical Education, Training, and Research, the Jette Christensen Early Career Professional Grant will provide funding for the development of the next generation of industry leaders which is reflective of one of Jette’s many passions.
Executives from Financial Industry Regulatory Authority, Subway, Macy’s, Inc., Conair LLC, Marcum, Schulte Roth & Zabel LLP & Hackensack Meridian Health Recognized for their Achievements
NEW YORK, Nov. 9, 2023 /PRNewswire-PRWeb/ — NewYorkCIO announced the winners of its 2023 ORBIE® Awards. NewYorkCIO recognized technology executives in seven key categories – Leadership, Global, Large Enterprise, Enterprise, Large Corporate, Corporate, & Healthcare. The Awards were presented at the New York ORBIE Awards at Ziegfeld Ballroom.
“Member-led, non-commercial programs like the ORBIE Awards, build meaningful professional relationships with colleagues facing similar challenges, solving problems and avoiding pitfalls,” said Andrea Markstrom, NewYorkCIO Chair. “Successful leaders understand the ‘superpower’ of trusted relationships. In any gathering of technology leaders, the answer is in the room.”
The 2023 New York ORBIE Award winners are:
Steven Randich, EVP & CIO, Financial Industry Regulatory Authority received the Leadership ORBIE.
Donagh Herlihy, CDO & CIO, Subway received the Global ORBIE for organizations over $12 billion annual revenue & multi-national operations.
Laura Miller, CIO, Macy’s, Inc. received the Large Enterprise ORBIE for organizations over $12 billion annual revenue.
Jon Harding, SVP, Global CIO, Conair LLC received the Enterprise ORBIE for organizations over $2.5 billion annual revenue.
Peter Scavuzzo, Principal, CIO & CDO, Marcum received the Large Corporate ORBIE for organizations over $1 billion annual revenue.
Andrea Markstrom, CIO, Schulte Roth & Zabel LLP received the Corporate ORBIE for organizations up to $1 billion annual revenue.
Mark Eimer, SVP, Associate CIO & CTO, Hackensack Meridian Health received the Healthcare ORBIE for hospitals and healthcare organizations.
The ORBIE Awards is the premier technology executive recognition program in the United States. Since inception in 1998, over 700 technology leaders have received the prestigious ORBIE Award. The ORBIE honors chief information officers who have demonstrated excellence in leadership. Finalists and winners are selected by an independent peer review process, led by prior ORBIE recipients, based upon:
Leadership and management effectiveness
Business value created by technology innovation
Engagement in industry and community endeavors
The New York ORBIE Awards keynote was delivered by Anna Ransley, Chief Digital Information Officer, Quaker Houghton, who was interviewed by Robert Field, Board Member, Senior Advisor, RAVIA Global Services. Nearly 450 guests attended, representing leading Greater New York organizations and their technology partners.
The 2023 New York ORBIE Awards was made possible by the following sponsors:
Bronze sponsors: Between Pixels, Authority Partners, Aladdin by BlackRock, Bourntec Solutions, Box, CDI, Druva, EY, Infosys, Juniper Networks, Microsoft, Protiviti, Pure Storage, Slalom
Media partner: Crain’s New York Business
National partner: Year Up
About NewYorkCIO
NewYorkCIO is the preeminent peer leadership network of Greater New York chief information officers. NewYorkCIO is one of over 30 chapters of the Inspire Leadership Network, a national membership organization comprised exclusively of CIOs from public and private businesses, government, education, healthcare and nonprofit institutions.
Achieve your leadership potential through NewYorkCIO: www.NewYorkCIO.org
Esteemed speakers, Kim Nguyen, Joel Schaerer and Alex Boudreau, will explore how AI is transforming medical imaging for oncology-focused clinical trials.
Join experts from Clario, Kim Nguyen, Director, Data Science, Data Science and Delivery; Joël Schaerer, Director, Tech Product Development, Research & Development — Imaging; and Alex Boudreau, Director, AI, Research & Development — Imaging, for the live webinar on Tuesday, November 28, 2023, at 11am EST (4pm GMT/UK). This webinar is Part 1 of Clario’s Oncology Webinar Series.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
At the core of the practice lies a philosophy rooted in aesthetic dentistry, a patient-centric approach, and an unwavering commitment to delivering extraordinary results. The practice has become a trusted destination for individuals seeking comprehensive cosmetic dental solutions through their innovative approach to care, including the Custom Smile Design Experience, an innovative blend of patient goals and clinical expertise.
Dr. King is highly regarded and recognized in her community and across the nation. She has been featured on CBS, CNN, The Doctors, Fox News, and in The Wall Street Journal, Time Magazine, InStyle, Vogue, Glamour, and USA Today. She was also selected as a featured cosmetic dentist on ABC’s show, “Extreme Makeover”, has been awarded “Best Cosmetic Dentist” by Best Self Atlanta, and is a 2020 Dental Hall of Fame inductee. She also directs an active philanthropy program benefiting the greater Atlanta area and people around the world. Over the past few decades, ACCD has donated more than $1M to more than 60 charities.
Atlanta Center for Cosmetic Dentistry offers a full range of cosmetic, restorative, and general dentistry services including porcelain veneers, prepless ultra-thin veneers, cosmetic bonding, teeth whitening, gum shaping, full mouth construction, anti-aging dentistry, Invisalign, implants, bridges, and crowns; all with an eye for beautiful natural results.
Atlanta Center for Cosmetic Dentistry dentists are members of the American Academy of Cosmetic Dentistry and are passionate about creating beautiful smiles. They are the only practice in the world with four accredited dentists!
Dr. Debra Gray King graduated from the University of Tennessee Center for the Health Sciences in Memphis, TN in 1987. She passed the accreditation examinations of the American Academy of Cosmetic Dentistry (AACD) in 1995 and went on to earn her fellowship in that Academy in 1999. AACD Fellowship is recognized as the highest level of competence in cosmetic dentistry, and there are only 81 dentists in the world who have earned this distinction.
“This partnership with DCA marks a transformative milestone in my professional journey,” shared Dr. King. “Through meticulous research, DCA emerged as the beacon of integrity and philosophy that aligned seamlessly with ACCD’s long-standing ethos of excellence and heartfelt patient care. I am invigorated by the promise of this partnership—preserving ACCD’s cherished legacy and magnifying its reach. Our combined vision and expertise herald a new era in cosmetic dentistry, crafting a future punctuated with captivating smiles.”
Dr. Charles C. Cooper received a B.A. with honors in Science Education at Mississippi State University, a Doctor of Medical Dentistry degree at the University of Mississippi School of Dentistry, and performed a General Practice Residency Program at the Medical College of Georgia School of Dentistry. Dr. Cooper earned his accreditation with the AACD in 2014.
Dr. Brett C. Reeve graduated with honors from Brigham Young University where he combined studies of Science and Spanish. He then went on to study Dentistry at the University of Southern California where he earned membership to “Omicron Kappa Upsilon”. Following graduation, Dr. Reeve served as a Captain in the United States Air Force for four years. In 2022 Dr. Reeve earned his accreditation with the AACD.
Dr. Laura Justice graduated with honors from the University of Kentucky College of Dentistry and has been practicing dentistry since 1989. She is an Accredited Fellow of the American Academy of Cosmetic Dentistry and serves on the board of the AACD, as well as being an Accreditation Examiner.
This affiliation reinforces Atlanta Center for Cosmetic Dentistry’s commitment to delivering the highest standard of dental care and ensuring access to innovative treatments for patients across the region. Additionally, this affiliation continues the rapid growth and momentum for the organization and expands DCA’s footprint in Georgia to 23 allied practices, and DCA’s total footprint to over 400 allied practices across the US.
“It’s with tremendous pride that we welcome the highly regarded practice of Atlanta Center for Cosmetic Dentistry to the DCA family,” shared Mandy Gast, DCA VP of Business Development. “Dr. King and her team are a vision into the future of what excellence in dentistry looks like, and we couldn’t be prouder to be their partner of choice.”
Dental Care Alliance’s mission is to advance the practice of dentistry by partnering with and supporting dental professionals to create a lifetime of healthy smiles. DCA currently supports over 400 allied practices and over 900 dentists across 23 states. DCA’s allied practices represent all dental specialties and treat patients under more than 150 brand names.
Media Contact
Molly Benz, Dental Care Alliance, 9419553150, [email protected], dentalcarealliance.com
With a dedicated privacy platform, healthcare organizations will be in compliance with HIPAA through technology that allows them to understand and govern the data shared to third-party tools. The Freshpaint Healthcare Privacy Platform includes:
Embedded video support: Allows healthcare organizations to use tools like YouTube on websites, while ensuring HIPAA compliance.
Web tracker monitoring: Gives marketers visibility into all third-party web trackers that may be running on websites and other digital platforms. With this information at their fingertips, companies can swiftly identify and address any potential privacy risks, ensuring patient data remains protected at all times.
Data governance verification: Gives healthcare organizations a clear picture of exactly what data is being shared to end destinations. This transparency not only builds trust but also ensures that organizations can quickly spot, and stop, any irregularities.
BAA-supported platform: Replaces non-HIPAA compliant tracking technologies and centralizes the collection of website visitor data in a platform backed by a Business Associate Agreement (BAA).
A safe-by-default approach: Helps eliminate human error by giving users an opt-in approach to data sharing for tools that aren’t HIPAA compliant.
Built-in deidentification: Creates an anonymous visitor ID and uses irreversible cryptographic hashing to de-identify data. Analytics platforms use that anonymous ID to create the complete visitor journey without knowing the visitor’s identity.
Industry-best marketing integrations: Prevent protected health information from inadvertently being shared with tools that healthcare marketers rely on, like analytics, direct response advertising, and programmatic ads.
“In today’s post-guidance world, many healthcare organizations are pleading for a clear and durable path forward that balances HIPAA compliance and high-performance marketing,” said Steven Fitzsimmons, CEO and co-founder of Freshpaint. “We are giving healthcare organizations the power to take a privacy-first approach to marketing, not just today but in the future as privacy regulations change.”
Freshpaint’s Healthcare Privacy Platform is already used by Baptist Health, Vybe Urgent Care, Boulder Community Health, and other healthcare organizations of all sizes. With Freshpaint’s Healthcare Privacy Platform, the healthcare sector can look forward to a future where digital innovation and patient privacy go hand in hand.
For more information about the platform or to schedule a demo, please visit www.freshpaint.io.
About Freshpaint
Freshpaint helps healthcare marketers unlock high-performance marketing in a HIPAA-compliant way through its Healthcare Privacy Platform. Freshpaint’s privacy-first approach to data sharing allows healthcare marketers to continue to use the most advanced ad, analytics, and personalization tools – without heavy engineering or long implementation times. Freshpaint is backed by leading investors such as Intel Capital and Y Combinator. For more information, visit www.freshpaint.io.
Dr. Rajasimha believes in the potential of human-centric digital technology to play a major role in decreasing the volume of patients who drop out of clinical trials by addressing some of the major impediments in the process, particularly the participation burden placed on the patients. For example, financial strain caused by a study that causes the study member to lose time at work. Often, clinical trials present a time constraint for those involved and this can result in financial strain or time away from the needs of their children or family members. Even traveling to the study location can be a hardship for some participants, if they do not have transportation or if they must rely on friends or family for rides.(3)
While it can be understandable why a participant may not be able to complete a clinical trial, the effect of patient dropouts extend far beyond the individual. The development of new treatments and drugs is involved and expensive, taking on average 10 to 15 years from creation to actual use and costing as much as $2 billion.(4) Enrollment and retention is obviously challenging, as these other statistics reveal:
19% of clinical trials were closed or terminated due to failure to recruit enough participants.(5)
More than half of ongoing clinical trials struggle with patient recruitment. Depending on the type of trial, this number can climb up to 85%.(6)
15% to 40% of enrolled participants drop out of their trial prior to completion.(6)
Bottlenecks or delays in this process can result in financial costs or even render the participation of other participants invalid if the study doesn’t mean the data thresholds required by the FDA. Ultimately, lack of participation in clinical trials can mean the trial fails and there are fewer treatments and greater health problems as a result.(7)
A New Age for Clinical Trials
Artificial intelligence or AI offers one way to achieve many of the goals for improving clinical trial retention. AI can help in this area of patient screening and recruitment by analyzing patient population data and identifying characteristics of patients that are most likely to benefit from the proposed drug or intervention. It can also improve the identification and recruitment of patients through electronic health record (EHR) data to match patients to trials.8 In addition, televisits or video visits in lieu of in-person travel or be away from work can easily begin to lower the burden. Capturing Patient Data using solutions such as remote electronic clinical outcomes assessments (eCOA) including clinician-report, observer-reported, Patient-Reported (ePRO) and (eDiaries) that allow survey participants to report and submit their data remotely and, in many cases, more accurately. In certain studies, such as use of biospecimens already collected for new research projects, informed consenting process can be completed remotely on a live interactive audio/video call.
It is not always about patient dropout; it is also about minimizing missed appointments and ensuring complete and high-quality data capture for all participants by clinical investigator teams. A big part of this is automating certain manual repetitive tasks such as reminders, automatic scheduling, rescheduling, alerts and notifications via SMS or email or audio/video channels. Jeeva’s goal is to improve patient retention by ensuring that trials are more accessible, a critical component of fulfilling their mission to help save lives and improve patient outcomes by accelerating clinical trials and addressing the most pressing problems in the clinical development process. To that end, Jeeva utilizes a unified patient portal platform that offers multiple ways to engage and communicate, from eConsent as a Service, eCoA, ePRO, ClinRO, ObsRO, PerfO, EDC, TeleVisits and VideoVisits, Patient Engagement Portal, and eDiary. TRIALMAGNETTM package was created to achieve the desired stickiness in clinical research.
In addition to patient retention technology, highly responsive study support and timely patient services are critical. This is where Sponsors, can seek to empower the clinical researchers with appropriate technology platform suitable for multi-center studies with flexibility to configure complex protocol designs.
“Ultimately, accessibility is what sponsors, investigators, and patients care about,” explains Dr. Rajasimha, who recently chaired the Indo US Bridging RARE Summit at George Mason UniversityOct 29 and 30, 2023. The summit included eight sessions including one on Sponsors of clinical trials. “We want to lead this market for sponsors of therapies for rare and chronic diseases to think in terms of how this technology can give accessibility to those that have been historically underrepresented so clinical trials can become universally accessible and effectively engage trial participants. This is aligned with the FDA’s priority and required to satisfy Diversity, Equity, Inclusion, and Access (DEIA) goals appropriate to a disease’s prevalence and epidemiology.”
At the Bridging RARE Summit, Dr. Rajasimha emphasized the need to get global with patient registries for rare diseases and the need to help emerging markets and LMICs to set up their own national registries or natural history studies. “By accelerating the standardized adoption of decentralized clinical trials, Sponsors can achieve efficiency and accessibility for all patients who may seek them. To realize the potential of AI (Artificial Intelligence) in rare diseases clinical research, we need to remove the bias in the data to make it more representative of the general population.” Rajasimha opined.
About Jeeva Informatics Solutions The personal experience of losing a child born with a rare congenital disorder and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of postdoctoral research experience at the NIH and FDA to accelerate therapies for rare and common conditions. He founded Jeeva with the mission of lowering the cost of drug development and accelerating the speed of clinical trials by purpose-building a modern technology platform that empowers sponsors to run clinical trials, with fewer fragmented systems, fewer employees, with significantly less burden on clinical researchers and patients, which has allowed for a more globally diverse population to access clinical trials remotely.
Today the Jeeva eClinical Trial platform supports sponsors and CROs across the globe helping reduce the logistical burdens on patients and study teams by over 70%. Its complete suite of technology supports fully decentralized and hybrid clinical trials and has resulted in being selected by research hospitals, CROs, and sponsors developing pioneering therapeutics such as Frantz Viral Therapeutics and ImmunoACT. The Virginia-based company’s modular cloud-resident software-as-a-service is highly scalable and facilitates patient enrollment, engagement, and evidence generation in clinical trials from one login from any browser-enabled mobile device. Visit https://jeevatrials.com/
References 1) Alexander, Walter. :”The Uphill Path to Successful Clinical Trials”; PT; April 2013; ncbi.nlm.nih.gov/pmc/articles/PMC3684189/. 2) Little, Roderick J., et. al.; “The Prevention and Treatment of Missing Data in Clinical Trials”; The New England Journal of Medicine; October 4, 2012; nejm.org/doi/full/10.1056/nejmsr1203730. 3) “6 reasons patients drop out of clinical trials and 6 ways to fix it”; PMLive, May 12, 2021; pmlive.com/pmhub/clinical_research/couch_integrated_marketing/white_papers_and_resources/6_reasons_patients_drop_out_of_clinical_trials_and_6_ways_to_fix_it. 4) Chaudhari, Nayan, Renju Ravi, Nithya J. Gogtay, and Urmila M. Thatte; “Recruitment and retention of the participants in clinical trials: Challenges and solutions”; Perspectives in Clinical Research; April-June 2020; ncbi.nlm.nih.gov/pmc/articles/PMC7342338/. 5) Grant D. Huang, Jonca Bull, Kelly Johnston McKee, Elizabeth Mahon, Beth Harper, Jamie N. Roberts; “Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative”; Contemporary Clinical Trials; March 2018; sciencedirect.com/science/article/pii/S155171441730753X 6) Ashton, Tiffany; “A Primer on the Importance of Recruitment and Retention in Clinical Trials”; Clinical Researcher; April 18, 2023; acrpnet.org/2023/04/a-primer-on-the-importance-of-recruitment-and-retention-in-clinical-trials/. 7) Fogel, David; “Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review”; Contemp Clin Trials Commun; August 7, 2018; ncbi.nlm.nih.gov/pmc/articles/PMC6092479/. 8) Hu-Rodgers, Tina; “2 Key Areas To Leverage AI/ML For More Successful Clinical Trials”; Clinical Leader; January 3, 2023; clinicalleader.com/doc/key-areas-to-leverage-ai-ml-for-more-successful-clinical-trials-0001.
“The Veterans Benefits Banking Program launched in 2019 to provide Veterans, beneficiaries, and caregivers with a safe, reliable, and inexpensive way to access their monetary benefits,” said Major General (Ret.) Steven J. Lepper, American Military Banks of America president and CEO. “What started with four financial institutions has grown to 86 and counting.”
The Department of Veterans Affairs, a founding partner of VBBP, shared how VBBP brought to light other financial issues unique to the Veteran community. VA Secretary McDonough: “Veterans deserve to get their benefits in the safest, most secure way possible — and that’s what the Veterans Benefits Banking Program delivers. Expanding this great program, to include financial counseling and education, will have a real impact on Veterans’ lives [by] helping protect and grow the benefits they’ve earned.”
The partnership behind VetCents includes financial wellness provider LifeCents who created the customized financial health platform for Veterans, beneficiaries, and caregivers to access financial wellness tools and resources.
“VetCents is a next-generation approach to improve access for Veterans, beneficiaries, and caregivers to the myriad of benefits available to them through the VA,” said Blake Allison, CEO and Founder, LifeCents. “It also offers an interactive and engaging experience that is designed specifically to help Veterans and their families improve their financial well-being and achieve financial security.”
Wells Fargo Foundation, a key supporter of VBBP and now VetCents, leveraged its experience and success in creating financial wellness programs for niche and marginalized communities.
“Supporting VetCents was a perfect fit with Wells Fargo’s goal to strengthen the financial health of our nation’s Veterans,” said Bonnie Wallace, head of Financial Health Philanthropy, Wells Fargo Foundation. “VBBP and VetCents can directly address the wide array of financial stressors that the Veteran community faces and connect them to the resources and support needed to improve their financial situations.”
In addition to encouraging banks of all sizes to join the VBBP program, the American Bankers Association Foundation serves as the 501(c)(3) nonprofit fiscal sponsor for managing donations that fund the VBBP.
“We’re proud to support the VBBP which is making a real difference in the lives of Veterans,” said Lindsay Torrico, executive director of the ABA Foundation. “We are also excited about the opportunity to get more of America’s banks involved in this important work. Adding the VetCents initiative will help in that effort.”
For photos and information from today’s click here.
About the ABA Foundation
Through its leadership, partnerships, and national programs, ABA’s Community Engagement Foundation (dba ABA Foundation), a 501(c)3, helps bankers provide financial education to individuals at every age, elevate issues around affordable housing and community development, and achieve corporate social responsibility objectives to improve the well-being of their customers and their communities.
About the Association of Military Banks of America
The Association of Military Banks of America (AMBA) was founded in 1959. AMBA is a not-for-profit association of banks operating on military installations, banks not located on military installations but serving military customers, and military banking facilities designated by the U.S. Treasury. The association’s membership includes both community banks and large multinational financial institutions, all of which are insured by the Federal Deposit Insurance Corporation.
About the Department of Veterans Affairs
The VA’s primary mission is to fulfill President Lincoln’s promise to care for those who have served in our nation’s military and for their families, caregivers, and survivors. In addition to the primary mission, VA carries out four specific missions to make good on its commitment to Veterans and other beneficiaries: Veterans Health Care, Veterans Benefits, National Cemeteries, and national preparedness for responding to war, terrorism, national emergencies, and natural disasters.
About LifeCents
LifeCents (www.lifecents.com) is a financial wellness and technology company that empowers people to acquire the knowledge, build the habits, and gain the confidence they need to make smarter everyday decisions. The company’s award-winning digital wellness platform helps people become financially aware, savvy, and engaged which is of great value to businesses and communities.
Beacon will also compliantly enable MSLs to assemble custom presentations to meet the individual information needs of their Key Opinion Leaders (KOLs). Additionally, Beacon’s hybrid engagement functionality will provide unique, industry-specific features to enrich Sage’s virtual meetings across leading video conferencing platforms like Zoom and Teams. It will also power in-person meetings with HCPs using both tablets and laptops where data service is unavailable.
Beacon’s unifying scientific exchange workflow will seamlessly integrate into Sage’s broader enterprise CMS-CRM eco-system, providing Sage leadership with access to even more comprehensive content and engagement metrics for strategic decision making.
“Alucio’s Beacon platform will streamline and elevate our field based scientific exchange activities to help strengthen our relationships with HCPs”, said Colville Brown, Vice President – Global Medical Affairs Depression Franchise. “Beacon was developed specifically for medical affairs needs and provides us with the modern capabilities we were seeking to support our ambitious growth plans.”
Sage adds to Alucio’s fast-growing roster of life science companies that have become Beacon customers. The platform can support both large and small pharma, biotech, and medical device companies seeking to manage and distribute scientific content more efficiently and expand their relationships with both medical KOLs and payers.
“We are thrilled that Sage selected Beacon as part of their Medical Affairs and Field Medical vision”, said Jeff Asada, Co-Founder and Head of Customer Success at Alucio, “We look forward to supporting their growing commercialization success while ensuring that Sage’s field medical team can deepen KOL relationships as part of Sage’s omnichannel orchestration efforts.”
About Alucio: Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact: Lisa Amin at [email protected] (925) 788-3533.
Since 2011, eLuma has sought a vision to help millions of students and their families access affordable and high-quality therapy and support. Working with experienced and licensed clinicians, eLuma delivers unmatched therapy services at a per-student level, ensuring that every student receives the mental health and special education services that they need. With over 40% of the nation’s public schools reporting that it’s very difficult to fill mental health professional roles, eLuma helps school districts realize their capacity and capabilities to care for students at every level of the multi-tiered system of support (MTSS).
“Earning a Top Workplaces award is a badge of honor for companies, especially because it comes authentically from their employees,” said Eric Rubino, Energage CEO. “That’s something to be proud of. In today’s market, leaders must ensure they’re allowing employees to have a voice and be heard. That’s paramount. Top Workplaces do this, and it pays dividends.”
eLuma believes in leading with passion, compassion and drive in everything they do from providing mental health support for its employees to offering no-cost financial coaching. eLuma prioritizes the well-being of its employees within its robust benefits package, yearly company-wide summit, company closures for wellness and more. eLuma ensures its people are not only given the tools they need to succeed, but the time and space to take care of their physical, mental and emotional well-being.
About eLuma eLuma is the premier provider of live, online therapy, assessment, and software solutions for K-12 education. With a national network of high-quality therapists and educators, an innovative software platform, and a game-changing case management system, eLuma doesn’t just fill a need, they create a customized solution that blends online therapy with districts onsite services to help support teams, bolster compliance, and ultimately create better student outcomes. For more information, visit eluma.com.
About Energage Making the world a better place to work‥together.™ Energage is a purpose-driven company that helps organizations turn employee feedback into useful business intelligence and credible employer recognition through Top Workplaces.‥Built on 17 years of culture research and the results from 27 million employees surveyed across more than 70,000 organizations, ‥Energage delivers the most accurate competitive benchmark available.‥With access to a unique combination of‥patented analytic tools and expert guidance, Energage customers lead the competition with an engaged workforce and an opportunity to gain recognition for their people-first approach to culture.‥For more information or to nominate your organization,‥visit energage.com or topworkplaces.com.
